Fig. 7From: Effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysisMeta-analysis of the effect of Sodium–glucose cotransporter 2 (SGLT2) inhibitors on P1NP (A), osteocalcin (B) and TRACP-5b (C) compared with placebo. P1NP, Procollagen type 1 N-terminal propeptide; TRACP-5b, Tartrate resistant acid phosphatase-5bBack to article page